Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications

Environmental Science and Pollution Research

Volumn 23, Issue 2, 2016, Pages 1954-1959

  Bajaj, Priyanka ^a   Kanaujia, Pawan Kumar ^a   Singh, Nambram Somendro ^a   Sharma, Shalu ^a   Kumar, Shakti ^b   Virdi, Jugsharan Singh ^a  

^a UNIVERSITY OF DELHI   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY GUWAHATI   (India)

Author keywords

Aquatic environment; CMY 42; CTX M 15; E. coli; PMQR; QRDR

Indexed keywords

ANTIBIOTIC RESISTANCE; AQUATIC ENVIRONMENT; BACTERIUM; CONCENTRATION (COMPOSITION); DRUG RESISTANCE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN ACTIVITY; KNOWLEDGE; PUBLIC HEALTH;

DELHI; INDIA; YAMUNA RIVER;

ESCHERICHIA COLI;

AMPC BETA-LACTAMASES; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; ESCHERICHIA COLI PROTEIN; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; GENETICS; HUMAN; INDIA; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PLASMID; PUBLIC HEALTH;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; INDIA; MICROBIAL SENSITIVITY TESTS; PLASMIDS; PUBLIC HEALTH; QUINOLONES; WATER MICROBIOLOGY;

EID: 84954387918     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-015-5609-x     Document Type: Article

References (36)

1. Adnan N, Sultana M, Islam OK, Nandi SP, Hossain MA (2013) Characterization of ciprofloxacin resistant extended spectrum β-lactamase (ESBL) producing Escherichia spp. from clinical waste water in Bangladesh. Adv Biosci Biotechnol 4:15–23. doi:10.4236/abb.2013.47A2003
2. Bagel S, Hüllen V, Wiedemann B, Heisig P (1999) Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli. Antimicrob Agents Chemother 43:868–875
3. Bajaj P, Singh NS, Kanaujia PK, Virdi JS (2015) Distribution and molecular characterization of genes encoding CTX-M and AmpC β-lactamases in Escherichia coli isolated from an Indian urban aquatic environment. Sci Total Environ 505:350–356. doi:10.1016/j.scitotenv.2014.09.084
4. Bergenholtz RD, Jorgensen MS, Hansen LH, Jensen LB, Hasman H (2009) Characterization of genetic determinants of extended-spectrum cephalosporinases (ESCs) in Escherichia coli isolates from Danish and imported poultry meat. J Antimicrob Chemother 64:207–209. doi:10.1093/jac/dkp168
5. Carattoli A (2009) Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 53:2227–2238. doi:10.1128/AAC.01707-08
6. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ (2005) Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63:219–228. doi:10.1016/j.mimet.2005.03.018
7. Chandran SP, Diwan V, Tamhankar AJ, Joseph BV, Rosales-Klintz S, Mundayoor S, Lundborg CS, Macaden R (2014) Detection of carbapenem resistance genes and cephalosporin, and quinolone resistance genes along with oqxAB gene in Escherichia coli in hospital wastewater: a matter of concern. J Appl Microbiol 117:984–995. doi:10.1111/jam.12591
8. Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. M100-S22. CLSI, Wayne, PA
9. Dhanji H, Murphy NM, Akhigbe C, Doumith M, Hope R, Livermore DM, Woodford N (2011) Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum β-lactamase from UK river water. J Antimicrob Chemother 66:512–516. doi:10.1093/jac/dkq472
10. Diwan V, Chandran SP, Tamhankar AJ, Stålsby Lundborg C, Macaden R (2012) Identification of extended-spectrum β-lactamase and quinolone resistance genes in Escherichia coli isolated from hospital wastewater from central India. J Antimicrob Chemother 67:857–859. doi:10.1093/jac/dkr564
11. Dolejska M, Frolkova P, Florek M, Jamborova I, Purgertova M, Kutilova I, Cizek A, Guenther S, Literak I (2011) CTX-M-15-producing Escherichia coli clone B2-O25b-ST131 and Klebsiella spp. isolates in municipal wastewater treatment plant effluents. J Antimicrob Chemother 66:2784–2790. doi:10.1093/jac/dkr363
12. Doumith M, Dhanji H, Ellington MJ, Hawkey P, Woodford N (2012) Characterization of plasmids encoding extended-spectrum β-lactamases and their addiction systems circulating among Escherichia coli clinical isolates in the UK. J Antimicrob Chemother 67:878–885. doi:10.1093/jac/dkr553
13. FAO/WHO/OIE (2007) Report of the joint FAO/WHO/OIE expert meeting on critically important antimicrobials. FAO, Rome
14. Hopkins KL, Davies RH, Threlfall EJ (2005) Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 25:358–373. doi:10.1016/j.ijantimicag.2005.02.006
15. Johnson TJ, Wannemuehler YM, Johnson SJ, Logue CM, White DG, Doetkott C, Nolan LK (2007) Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. Appl Environ Microbiol 73:1976–1983. doi:10.1128/AEM.02171-06
16. Kaper JB, Nataro JP, Mobley HL (2004) Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140. doi:10.1038/nrmicro818
17. Karczmarczyk M, Martins M, Quinn T, Leonard N, Fanning S (2011) Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals. Appl Environ Microbiol 77:7113–7120. doi:10.1128/AEM.00600-11
18. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO (2001) Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis 33:1288–1294. doi:10.1086/322667
19. CTX-M-1 between commensal Escherichia coli in pigs and farm workers. Antimicrob Agents Chemother 53:1709–1711. doi:10.1128/AAC.01014-08
20. Nakamura S, Nakamura M, Kojima T, Yoshida H (1989) gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 33:254–255
21. Nicolas-Chanoine MH, Bertrand X, Madec JY (2014) Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev 27:543–574. doi:10.1128/CMR.00125-13
22. Paltansing S, Kraakman ME, Ras JM, Wessels E, Bernards AT (2013) Characterization of fluoroquinolone and cephalosporin resistance mechanisms in Enterobacteriaceae isolated in a Dutch teaching hospital reveals the presence of an Escherichia coli ST131 clone with a specific mutation in parE. J Antimicrob Chemother 68:40–45. doi:10.1093/jac/dks365
23. Phan MD, Forde BM, Peters KM, Sarkar S, Hancock S, Stanton-Cook M, Ben Zakour NL, Upton M, Beatson SA, Schembri MA (2015) Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone. PLoS One 10(4):e0122369. doi:10.1371/journal.pone.0122369
24. Poirel L, Pitout JD, Calvo L, Rodriguez-Martinez JM, Church D, Nordmann P (2006) In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum β-lactamase. Antimicrob Agents Chemother 50:125–127. doi:10.1128/AAC.50.4.1525-1527.2006
25. Rodríguez-Baño J, Navarro MD, Romero L, Martínez-Martínez L, Muniain MA, Perea EJ, Pérez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089–1094. doi:10.1128/JCM.42.3.1089-1094.2004
26. Rodríguez-Martínez JM, Velasco C, García I, Cano ME, Martínez-Martínez L, Pascual A (2007) Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother 51:2236–2239. doi:10.1128/AAC.01444-06
27. Rodríguez-Martínez JM, Cano ME, Velasco C, Martínez-Martínez L, Pascual A (2011) Plasmid-mediated quinolone resistance: an update. J Infect Chemother 17:149–182. doi:10.1007/s10156-010-0120-2
28. Ruiz J (2003) Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother 51:1109–1117. doi:10.1093/jac/dkg222
29. Russo TA, Johnson JR (2003) Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect 5:449–456. doi:10.1016/S1286-4579(03)00049-2
30. Sáenz Y, Zarazaga M, Briñas L, Ruiz-Larrea F, Torres C (2003) Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals. J Antimicrob Chemother 51:1001–1005. doi:10.1093/jac/dkg168
31. Shaheen BW, Nayak R, Foley SL, Boothe DM (2013) Chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms among broad-spectrum-cephalosporin-resistant Escherichia coli isolates recovered from companion animals in the USA. J Antimicrob Chemother 68:1019–1024. doi:10.1093/jac/dks514
32. Sorlozano A, Gutierrez J, Jimenez A, de Dios Luna J, Martínez JL (2007) Contribution of a new mutation in parE to quinolone resistance in extended-spectrum-β-lactamase-producing Escherichia coli isolates. J Clin Microbiol 45(8):2740–2742. doi:10.1128/JCM.01093-07
33. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A (2009) Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev 22:664–689. doi:10.1128/CMR.00016-09
34. Stürenburg E, Mack D (2003) Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control. J Infect 47:273–295. doi:10.1016/S0163-4453(03)00096-3
35. Tacão M, Moura A, Correia A, Henriques I (2014) Co-resistance to different classes of antibiotics among ESBL-producers from aquatic systems. Water Res 48:100–107. doi:10.1016/j.watres.2013.09.021
36. Zurfluh K, Abgottspon H, Hächler H, Nüesch-Inderbinen M, Stephan R (2014) Quinolone resistance mechanisms among extended-spectrum β-lactamase (ESBL) producing Escherichia coli isolated from rivers and lakes in Switzerland. PLoS One 9:e95864. doi:10.1371/journal.pone.0095864